Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Pancreatic Carcinoma”

156 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 156 results

Testing effectiveness (Phase 2)Study completedNCT02558868
What this trial is testing

Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Zhejiang University 80
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT02959164
What this trial is testing

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaSarcoma
Mohammed Milhem 36
Early research (Phase 1)Study completedNCT02574663
What this trial is testing

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Who this might be right for
Pancreatic CancerColorectal CancerRectal Cancer+3 more
TG Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00365144
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 36
Large-scale testing (Phase 3)UnknownNCT02506842
What this trial is testing

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Who this might be right for
Stage ⅠA Pancreatic CancerStage ⅠB Pancreatic CancerStage ⅡA Pancreatic Cancer+1 more
Fudan University 300
Early research (Phase 1)Ended earlyNCT00598091
What this trial is testing

A Phase I/Expansion Study of Dasatinib

Who this might be right for
Refractory Solid TumorsPancreatic Adenocarcinoma
Duke University 30
Testing effectiveness (Phase 2)Study completedNCT00125021
What this trial is testing

Tarceva and Capecitabine for Pancreatic Cancer

Who this might be right for
Pancreatic CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT06015724
What this trial is testing

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaRefractory Non-Small Cell Lung Cancer
Georgetown University 54
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Testing effectiveness (Phase 2)Study completedNCT01423604
What this trial is testing

Study of Ruxolitinib in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Incyte Corporation 136
Early research (Phase 1)Active Not RecruitingNCT05721846
What this trial is testing

Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Inna Chen, MD 20
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)Study completedNCT01897415
What this trial is testing

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Who this might be right for
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
University of Pennsylvania 16
Large-scale testing (Phase 3)Study completedNCT01494506
What this trial is testing

Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Merrimack Pharmaceuticals 417
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Study completedNCT03985072
What this trial is testing

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

Who this might be right for
Tumor, SolidGall Bladder CancerCervical Cancer+3 more
Andes Biotechnologies 67
Load More Results